Interferon‐α activates interleukin‐1 receptor‐associated kinase 1 to induce regulatory T‐cell apoptosis in patients with systemic lupus erythematosus
Mingfang Li, Datang Yu, Yu Wang, Na Luo, Guang‐Ming Han, Bin Yang
Abstract
Abstract Impaired regulatory T‐cell (Treg) responses and upregulated interleukin‐1 receptor‐associated kinase 1 (IRAK1) expression are associated with the development of human systemic lupus erythematosus (SLE). Here, we show that the levels of upregulated IRAK1 expression in circulating Tregs are correlated with the percentages of apoptotic Tregs, Systemic Lupus Erythematosus Disease Activity Index scores, and serum complement C3 levels in SLE patients. High levels of plasma interferon (IFN)‐α in SLE patients induced IRAK1 phosphorylation to trigger Treg apoptosis, which was mitigated by IRAK1 inhibitor (IRAK‐Inh) treatment. Bioinformatics indicated that IRAK1 activation was related to the IFN‐α/β and mitogen‐activated protein kinase (MAPK) signaling in Tregs and IFN‐α treatment induced the p38 and MAPK/ERK kinase 3/6 phosphorylation, which was attenuated by IRAK‐Inh in Tregs. Treatment with IRAK‐Inh effectively alleviated renal injury and promoted the survival of lupus‐prone B6.MRL‐Fas lpr /Nju mice. Therefore, IFN‐α induced IRAK1 activation to promote Treg apoptosis, contributing to the pathogenesis of SLE and IFN‐α/IRAK1 may be therapeutic targets for SLE.